Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 224,852 |
|
|||||
| News | - | ||||||
| Day High | 1.195 | Low High |
|||||
| Day Low | 1.13 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0201 | -1.66% | 1.1899 | 09:33:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.16 | 1.13 | 1.195 | 1.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 399 | 224,852 | $ 1.16 | $ 261,364 | - | 0.4986 - 1.914 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:33:59 | 1,000 | $ 1.1899 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 38.8M | 32.06M | - | 0 | -37.34M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.54 | 1.72 | 1.13 | 1.42 | 1,720,637 | -0.3501 | -22.73% |
| 1 Month | 1.10 | 1.72 | 1.07 | 1.39 | 1,559,181 | 0.0899 | 8.17% |
| 3 Months | 0.608 | 1.72 | 0.59 | 1.18 | 1,468,071 | 0.5819 | 95.71% |
| 6 Months | 1.00 | 1.72 | 0.4986 | 1.01 | 1,227,936 | 0.1899 | 18.99% |
| 1 Year | 1.40 | 1.914 | 0.4986 | 1.08 | 730,792 | -0.2101 | -15.01% |
| 3 Years | 7.69 | 15.0789 | 0.4986 | 3.13 | 438,016 | -6.50 | -84.53% |
| 5 Years | 1.01 | 19.38 | 0.1021 | 1.95 | 2,397,005 | 0.1799 | 17.81% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
